Precipio Gets Extension to Meet Nasdaq Listing Requirement

Dec

Post-Transplant Viral Load Monitoring: Improving Practices and Clinical Considerations

Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.

Dec

Featured Webinar

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.

Dec

Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

Menu

Precipio Gets Extension to Meet Nasdaq Listing Requirement

To read the full story....

Breaking News

Agilent Q4 Revenues Rise 8 Percent

Novellus, Tempus Partner to Enroll Patients in BRAF Inhibitor Clinical Trial Program

Scope Fluidics Secures €6.2M Supporting Rapid MDx

Rare Variant Study Suggests Blood Pressure Traits May Have Ties to Development, Heart Conditions

Correlia Biosystems Closes $7M Series A Round

Twist Bioscience Fiscal Q4 Revenues More Than Double

Recent Headlines from
Precision Oncology News

SEngine Precision Medicine IDs Potential Ovarian Cancer Treatment Combos Using Organoid Approach

Reinsurer SCOR Offering Cancer Genomic Testing as Benefit for Policyholders, Life Insurance Clients

Cancer Patients With BRCA1/2 Mutations Respond Differently to Immunotherapy, Study Shows

Radiomics-Based Method Detects EGFR Mutation Status, Predicts NSCLC Therapy Benefit

Early Data in Hand, Verastem Marches Ahead With RAF-MEK Inhibitor Program in KRAS-mutated Cancers

Featured White Papers

Post-Transplant Viral Load Monitoring: Improving Practices and Clinical Considerations

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

What's Popular?

FDA Accepts Invitae Premarket Approval Submission for Stratafide Companion Diagnostic

Tumor, Germline Testing of Cancer Patients Can Give Discordant Results

Genentech, OneOncology Partner on Genomic Profiling for Personalized Cancer Care

Broad Institute DepMap Project Could Lead to Development of New Cancer Drugs

Burning Rock Adds New Data Supporting Cancer Screening Liquid Biopsy, Automated NGS Products

Sponsorships